WebFeb 15, 2024 · About Galera Therapeutics. Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutic candidates that have the potential to transform radiotherapy in cancer. ... Galera’s dependence on avasopasem manganese (GC4419); uncertainties … WebDec 15, 2024 · A new drug application for avasopasem (GC4419) was submitted to the FDA for the treatment of radiotherapy-induced severe oral mucositis in those diagnosed with head and neck cancer, according to a press release from Galera Therapeutics.
Syed Ashar Ali Shah, MD posted on LinkedIn
WebFind the latest Galera Therapeutics, Inc. (GRTX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Avasopasem NDA granted FDA priority ... WebWho is Galera Therapeutics Headquarters 2 W Liberty Blvd 100, Malvern, Pennsylvania, 19355, United States Phone Number (610) 725-1500 Website www.galeratx.com Revenue $6.3M Stock Symbol GRTX Industry Business Services General Business Services Galera Therapeutics's Social Media Is this data correct? View contact profiles from Galera … statue abraham lincoln washington dc
Galera Therapeutics, Inc. (GRTX) - Yahoo Finance
WebRedox Biology (Apr 2024) . Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients WebOct 26, 2024 · Galera Therapeutics Inc (NASDAQ: GRTX ) announced the presentation of one-year tumor and renal function outcomes data from its Phase 3 ROMAN trial of … WebDec 12, 2024 · About Galera Therapeutics. Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutic candidates that have the potential to transform radiotherapy in cancer. ... Galera’s dependence on avasopasem manganese (GC4419); uncertainties … statue alex thao